Literature DB >> 21862178

Extracorporeal albumin dialysis in three cases of acute calcium channel blocker poisoning with life-threatening refractory cardiogenic shock.

Nicolas Pichon1, Anthony Dugard, Marc Clavel, Jean Bernard Amiel, Bruno François, Philippe Vignon.   

Abstract

We describe 3 patients admitted to the medical-surgical ICU in a university hospital with life-threatening cardiogenic shock after the ingestion of high doses of calcium channel blockers (8.4 g sustained-release diltiazem, 4.2 g sustained-release diltiazem, and 14.4 g slow-release verapamil). Cardiovascular failure and cardiac conduction disturbances were unresponsive to the usual therapy (eg, intravenous injection of high doses of calcium, glucagon, hyperinsulinemia-euglycemia therapy, fluid resuscitation) and to increasing doses of simultaneous infusions of adrenergic agonists. Albumin dialysis with Molecular Adsorbents Recirculating System (MARS) therapy was performed because of its unique ability to selectively remove from circulation protein-bound toxins (and potentially drugs) that are not cleared by conventional hemodialysis. A single procedure was successfully performed in each patient, which was followed by rapid weaning of adrenergic agonist agents and full recovery of the life-threatening cardiovascular failure. At 2-year follow-up, patients were asymptomatic. Albumin dialysis with MARS therapy may be effective when used as a rescue procedure in patients presenting with sustained, life-threatening cardiogenic shock as a result of massive calcium channel blocker poisoning.
Copyright © 2011. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862178     DOI: 10.1016/j.annemergmed.2011.07.029

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

Review 1.  Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.

Authors:  Faouzi Saliba; Rafael Bañares; Fin Stolze Larsen; Alexander Wilmer; Albert Parés; Steffen Mitzner; Jan Stange; Valentin Fuhrmann; Stefan Gilg; Tarek Hassanein; Didier Samuel; Josep Torner; Samir Jaber
Journal:  Intensive Care Med       Date:  2022-09-06       Impact factor: 41.787

2.  The Efficacy of Albumin Dialysis in the Reversal of Refractory Vasoplegic Shock Due to Amlodipine Toxicity.

Authors:  Randi L Connor-Schuler; Jennifer M Carr; Matthew S Reaven; Bob T Bridgman; Deepa M Patel; Ram M Subramanian
Journal:  Crit Care Explor       Date:  2020-06-05

3.  Single-Pass Albumin Dialysis as Rescue Therapy for Pediatric Calcium Channel Blocker Overdose.

Authors:  Jenna Essink; Sydney Berg; Jaka Montange; Andrew Sankey; Veronica Taylor; Jeffrey Salomon
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

4.  Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center.

Authors:  Clément Monet; Audrey De Jong; Yassir Aarab; Lauranne Piron; Albert Prades; Julie Carr; Fouad Belafia; Gérald Chanques; Boris Guiu; Georges-Philippe Pageaux; Samir Jaber
Journal:  Crit Care       Date:  2022-09-19       Impact factor: 19.334

Review 5.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.